注册以创建品种、
财经事件和所关注作者内容的提醒
免费注册 已有账户? 登录
Midatech Pharma PLC是一家总部位于英国的药物输送技术公司。该公司专注于改善药物的生物递送和生物分配。该公司的技术包括Q-Sphera、MidaSolve和MidaCore。 Q-Sphera 技术专注于使用三维(3D)打印技术的长效注射剂。MidaCore技术平台使用超小金纳米颗粒(GNP)药物偶联物。MidaSolve Nano Inclusion技术可溶解在氢(pH)生物势下具有最小溶解度的分子,从而扩展可用的给药途径,包括直接向肿瘤给药。它拥有大约10个早期项目的管道,其中包括 MTD211(精神分裂症,MDD)、MTD219(预防、移植排斥)、MTX223、MTX213、MTX214、MTX110(胶质母细胞瘤)、MTX110(儿童脑癌(DIPG)),MTX110(成神经管细胞瘤)和MTX114(银屑病)。
名称 | 年龄 | 任期 | 标题 |
---|---|---|---|
Daniel McCurdy | 65 | - | Member of Scientific Advisory Board |
Sijmen de Vries | 63 | 2004 | Independent Non-Executive Director |
Simon Turton | 54 | 2014 | Senior Independent Non-Executive Director |
Michael J. Natan | - | - | Member of Scientific Advisory Board |
Francesco Stellaci | - | - | Chairman of Scientific Advisory Board |
Jean-Christophe Le Roux | - | - | Member of Scientific Advisory Board |
Silke Krol | - | - | Member of Scientific Advisory Board |
David Male | - | - | Member of Scientific Advisory Board |
Soledad Penades | - | - | Member of Scientific Advisory Board |
Lorraine O'Driscoll | - | - | Member of Scientific Advisory Board |
Stephen A. Stamp | 60 | 2019 | CEO, CFO, Company Secretary & Director |
Stephen Barry Parker | 65 | 2022 | Independent Non-Executive Chairman |
Ann Merchant | 58 | 2023 | Non-Executive Director |
确定屏蔽%USER_NAME%?
如果屏蔽,您和%USER_NAME%都无法看到相互在Investing.com上发布的信息。
%USER_NAME%已成功添加至屏蔽列表
由于您刚刚取消屏蔽此人,因此必须等待48小时才能重新屏蔽。
您举报该评论的原因为:
谢谢您!
您的举报将会被发送到管理员进行审核